Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Quita Colicos Gas Relief Drops

Last content change checked dailysee data sync status

Active ingredient
Dimethicone 20 mg/0.3 mL
Other brand names
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2014
Label revision date
January 7, 2026
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Dimethicone 20 mg/0.3 mL
Other brand names
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2014
Label revision date
January 7, 2026
Manufacturer
DLC Laboratories, Inc.
Registration number
M002
NDC root
24286-1533
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

De La Cruz Baby Gas Relief Drops are designed to help relieve the discomfort of gas in infants, which can often be caused by swallowing air or certain formulas and foods. This product is safe for newborns and infants, and it contains simethicone, an ingredient that works as an anti-gas agent to help alleviate bloating and discomfort.

These drops come in a convenient 1 FL OZ (30 mL) bottle and are flavored with natural cherry, making them more palatable for your little one. With up to 100 doses available, De La Cruz Baby Gas Relief Drops provide a gentle solution to help soothe your baby's tummy troubles.

Uses

If your baby is experiencing discomfort from gas, this medication can help relieve that discomfort. Gas in infants often occurs due to swallowing air or as a reaction to certain formulas or foods.

You can feel confident using this product, as it is safe for newborns and infants. It’s designed to provide comfort and ease for your little one during those fussy moments.

Dosage and Administration

Before you use the medication, make sure to shake the bottle well. To find the right dose for your baby, refer to the dosage chart provided. If possible, use your baby's weight to determine the dose; if not, you can use their age. Always use the enclosed dropper to measure the dosage. Fill the dropper to the recommended level and gently dispense the liquid into your baby's mouth, aiming for the inner cheek to make it easier for them to swallow.

You can give the medication after meals and at bedtime, or as directed by your doctor. Just remember not to exceed 12 doses in a single day. If you prefer, you can mix the dosage with 1 ounce of cool water, infant formula, or another suitable liquid to make it more palatable. After each use, be sure to clean the dropper thoroughly and put the original cap back on to keep it safe for next time.

What to Avoid

You can feel reassured that there are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. This means that, based on the available information, you do not need to worry about any particular restrictions or risks related to these aspects. Always consult with your healthcare provider if you have any questions or concerns about your treatment.

Side Effects

It's important to keep this medication out of reach of children. If you suspect an overdose, seek medical help immediately or contact a Poison Control Center.

While specific side effects are not detailed here, always be aware of how your body responds to any medication and consult your healthcare provider if you experience any unusual symptoms.

Warnings and Precautions

It's important to keep this medication out of reach of children to prevent accidental ingestion. If you suspect an overdose, seek medical help immediately or contact a Poison Control Center for assistance.

While there are no specific general precautions or laboratory tests mentioned, always be mindful of how you feel while taking any medication. If you experience any unusual symptoms or have concerns, don’t hesitate to reach out to your healthcare provider for guidance.

Overdose

If you suspect an overdose, it’s crucial to seek medical help immediately or contact a Poison Control Center. Signs of an overdose can vary, but they may include unusual symptoms that are more severe than typical side effects.

Always err on the side of caution—if you notice anything concerning, don’t hesitate to reach out for assistance. Your health and safety are the top priority.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that the safety of simethicone during pregnancy has not been established. Currently, there are no specific contraindications (conditions that would prevent use) mentioned for pregnant individuals, and there is no available data regarding potential risks to the fetus.

Before using simethicone, it is advisable to consult your healthcare provider to discuss any concerns or questions you may have. They can provide guidance tailored to your specific situation. Additionally, there are no recommended dosage modifications for pregnant individuals, so it's best to follow your healthcare provider's advice.

Lactation Use

When it comes to breastfeeding, there is currently no specific information available regarding the use of this medication for nursing mothers or its effects during lactation (the period of breastfeeding). This means that if you are breastfeeding, it’s important to consult with your healthcare provider to discuss any potential risks or considerations related to your specific situation. Always prioritize your health and the well-being of your baby when making decisions about medication use while nursing.

Pediatric Use

When it comes to giving this medication to your child, it's important to follow the recommended dosages based on their age and weight. For infants under 2 years old, the dose is 0.3 mL, especially if they weigh less than 24 pounds. For children over 2 years old, the appropriate dose increases to 0.6 mL, which is suitable for those who weigh more than 24 pounds.

Rest assured, this medication is considered safe for newborns and infants, so you can feel confident in its use for your little ones. Always consult with your healthcare provider if you have any questions or concerns about dosing for your child.

Geriatric Use

While there is no specific information about the use of QUITA COLICOS GAS RELIEF DROPS (simethicone liquid) in older adults, it's important to approach any medication with caution. Since the drug insert does not mention dosage adjustments or safety concerns for elderly patients, you should consult with a healthcare professional before using this product. They can provide personalized advice based on your health status and any other medications you may be taking. Always prioritize safety and ensure that any treatment is appropriate for your individual needs.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not change based on renal impairment. However, it’s always a good idea to discuss your kidney health with your healthcare provider, as they can offer personalized advice and monitor your condition effectively.

Make sure to keep your doctor informed about any changes in your kidney function, as they may need to adjust your treatment plan accordingly. Regular check-ups and open communication are key to managing your health safely.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (issues with liver function).

Always consult your healthcare provider for personalized advice and to discuss any concerns regarding your liver health and how it may relate to your treatment. They can help ensure that you receive the safest and most effective care.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. Currently, there are no specific drug interactions or laboratory test interactions noted for this medication. However, every individual’s health situation is unique, and your provider can help ensure that your treatment is safe and effective. Always feel free to ask questions and share all the medications and supplements you are using to avoid any potential issues.

Storage and Handling

To ensure the safety and effectiveness of your product, always check that the printed bottle wrap is intact before use; do not use it if the wrap is missing or broken. Store the product at room temperature, and avoid freezing it, as extreme temperatures can affect its quality. For your reference, the lot number and expiration date can be found on the bottom panel of the bottle, so be sure to check these details before use.

Additional Information

You will take this medication orally. There are no additional details available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences. If you have any questions or concerns about your treatment, be sure to discuss them with your healthcare provider.

FAQ

What is De La Cruz Baby Gas Relief Drops used for?

De La Cruz Baby Gas Relief Drops relieve the discomfort of infant gas frequently caused by air swallowing or certain formulas or foods.

Is De La Cruz Baby Gas Relief Drops safe for newborns?

Yes, De La Cruz Baby Gas Relief Drops are safe for newborns and infants.

What is the active ingredient in De La Cruz Baby Gas Relief Drops?

The active ingredient is Simethicone, which is an anti-gas agent.

How should I administer De La Cruz Baby Gas Relief Drops?

Shake well before use, find the right dose on the chart, and use the enclosed dropper to dispense the liquid slowly into the baby's mouth.

What is the recommended dosage for infants under 2 years?

For infants under 2 years, the recommended dosage is 0.3 mL.

What precautions should I take when using De La Cruz Baby Gas Relief Drops?

Keep the drops out of reach of children and seek medical help immediately in case of overdose.

Can I use De La Cruz Baby Gas Relief Drops during pregnancy?

The safety of simethicone during pregnancy has not been established, so consult a healthcare provider before use.

How should I store De La Cruz Baby Gas Relief Drops?

Store at room temperature, do not freeze, and ensure the bottle wrap is intact.

What flavor do De La Cruz Baby Gas Relief Drops have?

De La Cruz Baby Gas Relief Drops have a natural cherry flavor.

How many doses can I give in a day?

Do not exceed 12 doses per day.

Packaging Info

Below are the non-prescription pack sizes of Quita Colicos Gas Relief Drops (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Quita Colicos Gas Relief Drops.
Details

Drug Information (PDF)

This file contains official product information for Quita Colicos Gas Relief Drops, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of discomfort associated with infant gas, which may frequently result from air swallowing or specific formulas and foods. It is safe for use in newborns and infants.

Dosage and Administration

Healthcare professionals should instruct patients to shake the medication well before use. The appropriate dosage can be determined using the provided dosage chart; when possible, weight should be used for dosing, otherwise, age may be utilized.

The enclosed dropper must be used exclusively for dosing. To administer, fill the dropper to the recommended dosage level and dispense the liquid slowly into the baby's mouth, directing it toward the inner cheek. All dosages may be repeated as needed after meals and at bedtime, or as directed by a physician. It is important not to exceed 12 doses in a 24-hour period.

For ease of administration, the dosage may also be mixed with 1 ounce of cool water, infant formula, or other suitable liquids. After each use, the dropper should be cleaned thoroughly, and the original cap should be replaced to maintain the integrity of the product.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

It is imperative to keep this product out of reach of children to prevent accidental ingestion or misuse. In the event of an overdose, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay.

No specific general precautions or laboratory tests have been identified for this product. However, healthcare professionals should remain vigilant and monitor for any adverse effects or complications that may arise during use.

Side Effects

Patients should be advised to keep the medication out of reach of children. In the event of an overdose, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Quita Colicos Gas Relief Drops (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Quita Colicos Gas Relief Drops.
Details

Pediatric Use

Pediatric patients under 2 years of age, specifically infants weighing under 24 lbs, are recommended to receive a dosage of 0.3 mL. For children over 2 years of age, those weighing more than 24 lbs should be administered a dosage of 0.6 mL. The formulation is considered safe for use in newborns and infants.

Geriatric Use

There is no specific information regarding the use of QUITA COLICOS GAS RELIEF DROPS (simethicone liquid) in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise clinical judgment when considering the use of this medication in the geriatric population, taking into account the individual patient's health status and any potential risks associated with treatment. Monitoring for efficacy and safety is recommended, as with any medication administered to elderly patients.

Pregnancy

The safety of simethicone during pregnancy has not been established. There are no specific contraindications for its use during pregnancy; however, no data are available regarding potential risks to the fetus. As such, healthcare providers are advised to consult with pregnant patients or those planning to become pregnant before recommending simethicone. No specific dosage modifications for pregnant individuals are provided.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be vigilant in monitoring for symptoms that may arise from an overdose. While specific symptoms are not detailed in the provided information, it is essential to be aware that they can vary based on the substance involved and the individual patient’s response.

Management of an overdose typically involves supportive care and symptomatic treatment. Healthcare providers are advised to follow established protocols for overdose management, which may include monitoring vital signs, providing respiratory support, and administering specific antidotes if applicable.

In summary, timely medical intervention and appropriate management strategies are critical in addressing overdose situations effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to emphasize the potential risks associated with overdose. Patients should be instructed to seek medical help or contact a Poison Control Center immediately in the event of an overdose. This information is crucial for ensuring patient safety and promoting responsible use of the medication.

Storage and Handling

The product is supplied in a secure bottle, and it is imperative that it is not used if the printed bottle wrap is missing or broken. For optimal storage, the product should be kept at room temperature and must not be frozen. Users are advised to check the bottom panel of the bottle for the lot number and expiration date to ensure product integrity and safety.

Additional Clinical Information

The medication is administered orally. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Quita Colicos Gas Relief Drops, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Quita Colicos Gas Relief Drops, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.